カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

構造的心疾患介入装置のグローバル市場2023：心房インターベンションクラス、心血管インターベンションクラス

■ 英語タイトル：Global Structural Heart Disease Intervention Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG10906）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG10906
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器＆消耗品
■ ページ数：109
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[構造的心疾患介入装置のグローバル市場2023：心房インターベンションクラス、心血管インターベンションクラス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、構造的心疾患介入装置のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の構造的心疾患介入装置市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 構造的心疾患介入装置の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

構造的心疾患介入装置市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・心房インターベンションクラス、心血管インターベンションクラス

用途別セグメント
・先天性心疾患治療、心臓弁膜症治療、心筋症治療、動脈瘤&動脈弁疾患治療、その他

主要な市場プレーヤー
・Abbott Structural Heart、Philips、Japen Lifeline、Neovasc、Append Medical、Transverse Medical、Cardiomech、Thubrikar Aortic Valve Inc、Boston Scientific、Edwards Lifesciences Corporation、Biomerics、LivaNova PLC

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、構造的心疾患介入装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な構造的心疾患介入装置メーカーの企業概要、2019年～2022年までの構造的心疾患介入装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な構造的心疾患介入装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別構造的心疾患介入装置の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの構造的心疾患介入装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での構造的心疾患介入装置市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および構造的心疾患介入装置の産業チェーンを掲載しています。
・第14、15章では、構造的心疾患介入装置の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 構造的心疾患介入装置の概要
– 種類別分析（2018年vs2022年vs2029年）：心房インターベンションクラス、心血管インターベンションクラス
– 用途別分析（2018年vs2022年vs2029年）：先天性心疾患治療、心臓弁膜症治療、心筋症治療、動脈瘤&動脈弁疾患治療、その他
– 世界の構造的心疾患介入装置市場規模・予測
– 世界の構造的心疾患介入装置生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Abbott Structural Heart、Philips、Japen Lifeline、Neovasc、Append Medical、Transverse Medical、Cardiomech、Thubrikar Aortic Valve Inc、Boston Scientific、Edwards Lifesciences Corporation、Biomerics、LivaNova PLC
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：心房インターベンションクラス、心血管インターベンションクラス
・用途別分析2018年-2029年：先天性心疾患治療、心臓弁膜症治療、心筋症治療、動脈瘤&動脈弁疾患治療、その他
・構造的心疾患介入装置の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・構造的心疾患介入装置のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・構造的心疾患介入装置のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・構造的心疾患介入装置の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・構造的心疾患介入装置の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Structural Heart Disease Intervention Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Structural Heart Disease Intervention Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Atrial Interventional Class
1.3.3 Cardiovascular Intervention
1.4 Market Analysis by Application
1.4.1 Overview: Global Structural Heart Disease Intervention Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Congenital Heart Disease Treatment
1.4.3 Valvular Heart Disease Treatment
1.4.4 Cardiomyopathy Treatment
1.4.5 Aneurysm and Arterial Valve Disease Treatment
1.4.6 Others
1.5 Global Structural Heart Disease Intervention Devices Market Size & Forecast
1.5.1 Global Structural Heart Disease Intervention Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Structural Heart Disease Intervention Devices Sales Quantity (2018-2029)
1.5.3 Global Structural Heart Disease Intervention Devices Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Abbott Structural Heart
2.1.1 Abbott Structural Heart Details
2.1.2 Abbott Structural Heart Major Business
2.1.3 Abbott Structural Heart Structural Heart Disease Intervention Devices Product and Services
2.1.4 Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Structural Heart Recent Developments/Updates
2.2 Philips
2.2.1 Philips Details
2.2.2 Philips Major Business
2.2.3 Philips Structural Heart Disease Intervention Devices Product and Services
2.2.4 Philips Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Philips Recent Developments/Updates
2.3 Japen Lifeline
2.3.1 Japen Lifeline Details
2.3.2 Japen Lifeline Major Business
2.3.3 Japen Lifeline Structural Heart Disease Intervention Devices Product and Services
2.3.4 Japen Lifeline Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Japen Lifeline Recent Developments/Updates
2.4 Neovasc
2.4.1 Neovasc Details
2.4.2 Neovasc Major Business
2.4.3 Neovasc Structural Heart Disease Intervention Devices Product and Services
2.4.4 Neovasc Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Neovasc Recent Developments/Updates
2.5 Append Medical
2.5.1 Append Medical Details
2.5.2 Append Medical Major Business
2.5.3 Append Medical Structural Heart Disease Intervention Devices Product and Services
2.5.4 Append Medical Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Append Medical Recent Developments/Updates
2.6 Transverse Medical
2.6.1 Transverse Medical Details
2.6.2 Transverse Medical Major Business
2.6.3 Transverse Medical Structural Heart Disease Intervention Devices Product and Services
2.6.4 Transverse Medical Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Transverse Medical Recent Developments/Updates
2.7 Cardiomech
2.7.1 Cardiomech Details
2.7.2 Cardiomech Major Business
2.7.3 Cardiomech Structural Heart Disease Intervention Devices Product and Services
2.7.4 Cardiomech Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cardiomech Recent Developments/Updates
2.8 Thubrikar Aortic Valve Inc
2.8.1 Thubrikar Aortic Valve Inc Details
2.8.2 Thubrikar Aortic Valve Inc Major Business
2.8.3 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Product and Services
2.8.4 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thubrikar Aortic Valve Inc Recent Developments/Updates
2.9 Boston Scientific
2.9.1 Boston Scientific Details
2.9.2 Boston Scientific Major Business
2.9.3 Boston Scientific Structural Heart Disease Intervention Devices Product and Services
2.9.4 Boston Scientific Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boston Scientific Recent Developments/Updates
2.10 Edwards Lifesciences Corporation
2.10.1 Edwards Lifesciences Corporation Details
2.10.2 Edwards Lifesciences Corporation Major Business
2.10.3 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Product and Services
2.10.4 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Edwards Lifesciences Corporation Recent Developments/Updates
2.11 Biomerics
2.11.1 Biomerics Details
2.11.2 Biomerics Major Business
2.11.3 Biomerics Structural Heart Disease Intervention Devices Product and Services
2.11.4 Biomerics Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Biomerics Recent Developments/Updates
2.12 LivaNova PLC
2.12.1 LivaNova PLC Details
2.12.2 LivaNova PLC Major Business
2.12.3 LivaNova PLC Structural Heart Disease Intervention Devices Product and Services
2.12.4 LivaNova PLC Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 LivaNova PLC Recent Developments/Updates
3 Competitive Environment: Structural Heart Disease Intervention Devices by Manufacturer
3.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Structural Heart Disease Intervention Devices Revenue by Manufacturer (2018-2023)
3.3 Global Structural Heart Disease Intervention Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Structural Heart Disease Intervention Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Structural Heart Disease Intervention Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Structural Heart Disease Intervention Devices Manufacturer Market Share in 2022
3.5 Structural Heart Disease Intervention Devices Market: Overall Company Footprint Analysis
3.5.1 Structural Heart Disease Intervention Devices Market: Region Footprint
3.5.2 Structural Heart Disease Intervention Devices Market: Company Product Type Footprint
3.5.3 Structural Heart Disease Intervention Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Structural Heart Disease Intervention Devices Market Size by Region
4.1.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2029)
4.1.3 Global Structural Heart Disease Intervention Devices Average Price by Region (2018-2029)
4.2 North America Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.3 Europe Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.5 South America Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
5.2 Global Structural Heart Disease Intervention Devices Consumption Value by Type (2018-2029)
5.3 Global Structural Heart Disease Intervention Devices Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
6.2 Global Structural Heart Disease Intervention Devices Consumption Value by Application (2018-2029)
6.3 Global Structural Heart Disease Intervention Devices Average Price by Application (2018-2029)
7 North America
7.1 North America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
7.2 North America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
7.3 North America Structural Heart Disease Intervention Devices Market Size by Country
7.3.1 North America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
8.2 Europe Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
8.3 Europe Structural Heart Disease Intervention Devices Market Size by Country
8.3.1 Europe Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Structural Heart Disease Intervention Devices Market Size by Region
9.3.1 Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
10.2 South America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
10.3 South America Structural Heart Disease Intervention Devices Market Size by Country
10.3.1 South America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Structural Heart Disease Intervention Devices Market Size by Country
11.3.1 Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Structural Heart Disease Intervention Devices Market Drivers
12.2 Structural Heart Disease Intervention Devices Market Restraints
12.3 Structural Heart Disease Intervention Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Structural Heart Disease Intervention Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Structural Heart Disease Intervention Devices
13.3 Structural Heart Disease Intervention Devices Production Process
13.4 Structural Heart Disease Intervention Devices Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Structural Heart Disease Intervention Devices Typical Distributors
14.3 Structural Heart Disease Intervention Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Structural Heart Disease Intervention Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Structural Heart Disease Intervention Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Structural Heart Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Structural Heart Major Business
Table 5. Abbott Structural Heart Structural Heart Disease Intervention Devices Product and Services
Table 6. Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Structural Heart Recent Developments/Updates
Table 8. Philips Basic Information, Manufacturing Base and Competitors
Table 9. Philips Major Business
Table 10. Philips Structural Heart Disease Intervention Devices Product and Services
Table 11. Philips Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Philips Recent Developments/Updates
Table 13. Japen Lifeline Basic Information, Manufacturing Base and Competitors
Table 14. Japen Lifeline Major Business
Table 15. Japen Lifeline Structural Heart Disease Intervention Devices Product and Services
Table 16. Japen Lifeline Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Japen Lifeline Recent Developments/Updates
Table 18. Neovasc Basic Information, Manufacturing Base and Competitors
Table 19. Neovasc Major Business
Table 20. Neovasc Structural Heart Disease Intervention Devices Product and Services
Table 21. Neovasc Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Neovasc Recent Developments/Updates
Table 23. Append Medical Basic Information, Manufacturing Base and Competitors
Table 24. Append Medical Major Business
Table 25. Append Medical Structural Heart Disease Intervention Devices Product and Services
Table 26. Append Medical Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Append Medical Recent Developments/Updates
Table 28. Transverse Medical Basic Information, Manufacturing Base and Competitors
Table 29. Transverse Medical Major Business
Table 30. Transverse Medical Structural Heart Disease Intervention Devices Product and Services
Table 31. Transverse Medical Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Transverse Medical Recent Developments/Updates
Table 33. Cardiomech Basic Information, Manufacturing Base and Competitors
Table 34. Cardiomech Major Business
Table 35. Cardiomech Structural Heart Disease Intervention Devices Product and Services
Table 36. Cardiomech Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cardiomech Recent Developments/Updates
Table 38. Thubrikar Aortic Valve Inc Basic Information, Manufacturing Base and Competitors
Table 39. Thubrikar Aortic Valve Inc Major Business
Table 40. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Product and Services
Table 41. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Thubrikar Aortic Valve Inc Recent Developments/Updates
Table 43. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 44. Boston Scientific Major Business
Table 45. Boston Scientific Structural Heart Disease Intervention Devices Product and Services
Table 46. Boston Scientific Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boston Scientific Recent Developments/Updates
Table 48. Edwards Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Edwards Lifesciences Corporation Major Business
Table 50. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Product and Services
Table 51. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Edwards Lifesciences Corporation Recent Developments/Updates
Table 53. Biomerics Basic Information, Manufacturing Base and Competitors
Table 54. Biomerics Major Business
Table 55. Biomerics Structural Heart Disease Intervention Devices Product and Services
Table 56. Biomerics Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Biomerics Recent Developments/Updates
Table 58. LivaNova PLC Basic Information, Manufacturing Base and Competitors
Table 59. LivaNova PLC Major Business
Table 60. LivaNova PLC Structural Heart Disease Intervention Devices Product and Services
Table 61. LivaNova PLC Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. LivaNova PLC Recent Developments/Updates
Table 63. Global Structural Heart Disease Intervention Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Structural Heart Disease Intervention Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Structural Heart Disease Intervention Devices Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Structural Heart Disease Intervention Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Structural Heart Disease Intervention Devices Production Site of Key Manufacturer
Table 68. Structural Heart Disease Intervention Devices Market: Company Product Type Footprint
Table 69. Structural Heart Disease Intervention Devices Market: Company Product Application Footprint
Table 70. Structural Heart Disease Intervention Devices New Market Entrants and Barriers to Market Entry
Table 71. Structural Heart Disease Intervention Devices Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Structural Heart Disease Intervention Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Structural Heart Disease Intervention Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Structural Heart Disease Intervention Devices Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Structural Heart Disease Intervention Devices Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Structural Heart Disease Intervention Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Structural Heart Disease Intervention Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Structural Heart Disease Intervention Devices Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Structural Heart Disease Intervention Devices Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Structural Heart Disease Intervention Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Structural Heart Disease Intervention Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Structural Heart Disease Intervention Devices Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Structural Heart Disease Intervention Devices Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Structural Heart Disease Intervention Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Structural Heart Disease Intervention Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Structural Heart Disease Intervention Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Structural Heart Disease Intervention Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Structural Heart Disease Intervention Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Structural Heart Disease Intervention Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Structural Heart Disease Intervention Devices Raw Material
Table 131. Key Manufacturers of Structural Heart Disease Intervention Devices Raw Materials
Table 132. Structural Heart Disease Intervention Devices Typical Distributors
Table 133. Structural Heart Disease Intervention Devices Typical Customers
List of Figures
Figure 1. Structural Heart Disease Intervention Devices Picture
Figure 2. Global Structural Heart Disease Intervention Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Type in 2022
Figure 4. Atrial Interventional Class Examples
Figure 5. Cardiovascular Intervention Examples
Figure 6. Global Structural Heart Disease Intervention Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Application in 2022
Figure 8. Congenital Heart Disease Treatment Examples
Figure 9. Valvular Heart Disease Treatment Examples
Figure 10. Cardiomyopathy Treatment Examples
Figure 11. Aneurysm and Arterial Valve Disease Treatment Examples
Figure 12. Others Examples
Figure 13. Global Structural Heart Disease Intervention Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Structural Heart Disease Intervention Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Structural Heart Disease Intervention Devices Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Structural Heart Disease Intervention Devices Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Structural Heart Disease Intervention Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Structural Heart Disease Intervention Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Structural Heart Disease Intervention Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Structural Heart Disease Intervention Devices Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Structural Heart Disease Intervention Devices Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Structural Heart Disease Intervention Devices Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Structural Heart Disease Intervention Devices Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value Market Share by Region (2018-2029)
Figure 55. China Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Structural Heart Disease Intervention Devices Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Structural Heart Disease Intervention Devices Market Drivers
Figure 76. Structural Heart Disease Intervention Devices Market Restraints
Figure 77. Structural Heart Disease Intervention Devices Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Structural Heart Disease Intervention Devices in 2022
Figure 80. Manufacturing Process Analysis of Structural Heart Disease Intervention Devices
Figure 81. Structural Heart Disease Intervention Devices Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source

※参考情報

構造的心疾患介入装置とは、心臓の解剖学的構造に関連する疾患の治療を目的とした医療機器や装置の総称です。これらの装置は、伝統的な心臓手術に代わる低侵襲な方法として、心臓の構造に直接的に介入することができるため、患者の回復を早め、合併症のリスクを低減することが期待されています。ここでは、構造的心疾患介入装置の定義、特徴、種類、用途、および関連技術について詳述いたします。

まず、構造的心疾患とは、先天的な心臓病や後天的な心疾患を指し、心臓の壁や弁、血管の問題に関連していることが多いです。これには、心房中隔欠損症（ASD）、心室中隔欠損症（VSD）、大動脈弁狭窄症、僧帽弁逆流症などが含まれます。これらの疾患は、心臓の機能を低下させたり、心不全を引き起こしたりする可能性があるため、早期の診断と適切な治療が求められます。

構造的心疾患介入装置の特徴としては、以下の点が挙げられます。まず、低侵襲であることです。従来の手術に比べ、創外科的（オープンハート）手術を避けることができるため、患者の身体への負担が軽減されます。これにより、入院期間が短縮され、早期の社会復帰が可能となります。また、これらの装置は、特定の心疾患に特化して設計されているため、高い治療効果が期待できます。

次に、構造的心疾患介入装置の種類について見ていきます。主な装置には、以下のものがあります。

1. **心房中隔閉鎖デバイス（ASDクローザー）：** ASDの治療に用いられ、心房中隔に欠損がある部分を塞ぐために使用されます。この装置は、血流の異常を正常化することができ、心機能の改善をもたらします。

2. **心室中隔欠損デバイス（VSDクローザー）：** VSDの治療に用いられ、心室中隔の欠損部分を閉じるための装置です。心室内の圧力平衡を取り戻し、心不全のリスクを軽減します。

3. **経カテーテル的大動脈弁置換（TAVR）：** 大動脈弁狭窄症の患者に対して、経皮的に大動脈弁を置換する手法です。この方法では大動脈弁を新しい弁に置き換え、心臓の流れを改善します。

4. **経カテーテル僧帽弁クリップ（MitraClip）：** 僧帽弁逆流症の治療に用いられ、僧帽弁の閉じ方を改善するために使用されます。この装置により、逆流を減少させ、心機能を改善します。

このように、構造的心疾患介入装置は、心臓の特定の構造的な問題に対して適切な治療を行うための重要な道具となっています。

用途に関しては、これらの介入装置は、主に心房中隔欠損、心室中隔欠損、弁疾患など、さまざまな構造的心疾患の治療に使用されます。これにより、長期的な心機能の改善や心不全のリスクの低減が見込まれています。また、再発防止や合併症のリスクを軽減することができるため、患者の生活の質（QOL）を向上させる要素ともなります。

関連技術としては、画像診断技術が重要な役割を果たしています。心血管領域における画像診断は、構造的心疾患の診断や治療に不可欠です。例えば、心エコー（エコーカルディオグラフィー）、CTスキャン、MRIなどにより、正確な心臓の形や機能を把握することができます。これにより、適切な治療方針を決定し、施術の安全性と有効性を高めることができます。

さらに、カテーテル技術は、これらの装置を体内に正確に配置するために不可欠です。カテーテルは血管を介して心臓に到達するため、最小限の侵襲で治療を行うことが可能です。最近ではロボティクス技術も進展しており、手術の精度を向上させるために用いられることが増えています。

構造的心疾患介入装置は、治療技術の進展に伴い、日々進化しています。新しい材質やデザインの開発、新しい治療法の研究が進む中で、より多くの患者に対して有効な治療が可能になることが期待されています。今後の技術革新が、慢性的な心疾患に苦しむ多くの患者に新たな希望をもたらすことでしょう。具体的な材料や設計、治療法に関しても、研究が進むことでより洗練された製品が市場に登場する可能性があります。

最後に、構造的心疾患介入装置は、心臓病治療の重要な一翼を担う存在です。低侵襲性や高い治療効果、さらには患者のQOLの改善に寄与することで、今後もたくさんの患者に恩恵をもたらすことが期待されています。心臓疾患は依然として深刻な健康問題であり、医療技術の進歩がその克服に向けた鍵となることでしょう。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 末梢インターベンション製品のグローバル市場2023：アクセス＆閉鎖デバイス、ガイドワイヤー、カテーテル、その他
  • 世界の大動脈&末梢血管介入装置市場2023年：企業・地域・タイプ・用途別分析
  • 挿入可能型心臓モニターのグローバル市場2023：植込み型ループレコーダー（ILR）、挿入型心臓モニター（ICM）
  • ポータブル胎児心臓モニターのグローバル市場2023：ポケットドップラー、ウェアラブルデバイス
  • 小児用開胸器のグローバル市場2023：スライド、回転
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG10906 )"構造的心疾患介入装置のグローバル市場2023：心房インターベンションクラス、心血管インターベンションクラス" (英文：Global Structural Heart Disease Intervention Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。